prostaglandins, synthetic

Preferred Label : prostaglandins, synthetic;

MeSH definition : Compounds obtained by chemical synthesis that are analogs or derivatives of naturally occurring prostaglandins and that have similar activity.;

MeSH synonym : analogues, prostaglandin; analogs, pg; prostaglandin analogs; synthetic prostaglandins; pg analogs; prostaglandin analogues; analogs, prostaglandin; PG Analog; Analog, PG; Synthetic Prostaglandin; Prostaglandin, Synthetic; Prostaglandin Analogue; Analogue, Prostaglandin; Prostaglandin Analog; Analog, Prostaglandin;

MeSH annotation : GEN or unspecified only: prefer specifics; for synthetic prostaglandins not precoord, coord specific non-synthetic (natural) prostaglandin term (NIM) PROSTAGLANDINS, SYNTHETIC (IM); DF: PG SYN; general or unspecified; prefer specifics; for synthetic prostaglandins not precoord, coord specific non-synthetic (natural) prostaglandin term (NIM) and PROSTAGLANDINS, SYNTHETIC (IM);

Wikipedia link : https://en.wikipedia.org/wiki/Prostaglandin analogue;

Is substance : O;

Details

Origin ID

D011465;

UMLS CUI

C0033568;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Prostaglandin Analogue [NCIt concept]
- Prostaglandin analog (substance) [SNOMED CT concept]
Indexing information
- 10,10-difluoro-13-dehydroprostacyclin [MeSH Supplementary Concept]
- 13,14-didehydro-20-methylcarboprostacyclin [MeSH Supplementary Concept]
- 15-fluoro-13,14-dehydrocarbacyclin [MeSH Supplementary Concept]
- 15-ketoprostaglandin B1 [MeSH Supplementary Concept]
- 16,16-dimethylprostaglandin A2 methyl ester [MeSH Supplementary Concept]
- 17,20-dimethylisocarbacyclin [MeSH Supplementary Concept]
- 20-methyl-13,14-didehydro-2,4-inter-3-phenylene prostaglandin I2 [MeSH Supplementary Concept]
- 5,6-dihydroprostacyclin [MeSH Supplementary Concept]
- 5-methyleneisocarbacyclin [MeSH Supplementary Concept]
- 6,9-thiaprostacyclin [MeSH Supplementary Concept]
- 6a-carbaprostaglandin I3 [MeSH Supplementary Concept]
- 9,11-etheno-16-(4-fluorophenoxyprostaglandin) H2 [MeSH Supplementary Concept]
- 9-O-methanoprostaglandin I [MeSH Supplementary Concept]
- 9-deoxy-delta-9-prostaglandin D2 [MeSH Supplementary Concept]
- 9-fluoro-15-hydroxy-16-phenoxy-17,18,19,20-tetranor-5,13-prostadienoic acid [MeSH Supplementary Concept]
- APS 306 [MeSH Supplementary Concept]
- CG 4303 [MeSH Supplementary Concept]
- FCE 21258 [MeSH Supplementary Concept]
- HOE 892 [MeSH Supplementary Concept]
- OP 41483-alpha-cyclodextrin [MeSH Supplementary Concept]
- R 59274 [MeSH Supplementary Concept]
- RS 93427-007 [MeSH Supplementary Concept]
- TEI 9090 [MeSH Supplementary Concept]
- ZK 110841 [MeSH Supplementary Concept]
- azo analog I [MeSH Supplementary Concept]
- azo analog II [MeSH Supplementary Concept]
- carboprostacyclin [MeSH Supplementary Concept]
- cicaprost [MeSH Supplementary Concept]
- ciprostene [MeSH Supplementary Concept]
- naxaprostene [MeSH Supplementary Concept]
- nileprost [MeSH Supplementary Concept]
- nitriloprostaglandin I2 [MeSH Supplementary Concept]
- prostaglandin D3 [MeSH Supplementary Concept]
- prostaglandin I2 11-methyl ether [MeSH Supplementary Concept]
- prostaglandin I2 15-methyl ether [MeSH Supplementary Concept]
- prostaglandin bx [MeSH Supplementary Concept]
- rosaprostol [MeSH Supplementary Concept]
- taprostene [MeSH Supplementary Concept]
MeSH Descriptor(s) used for indexing
- prostaglandins [MeSH Descriptor]
Record concept(s)
- prostaglandins, synthetic [MeSH concept]
Related MeSH Supplementary Concept(s)
- (+)(-)-8,12-trans-9-oxo-prosta-5,14-dienoic acid [MeSH Supplementary Concept]
- 11-methoxime prostaglandin D2 [MeSH Supplementary Concept]
- 9 alpha,11 alpha,15 alpha-trihydroxy-16-phenoxy-17,18,19,20-tetranorprosta-4,5,13-trienoic acid [MeSH Supplementary Concept]
- 9-chloro-15-cyclohexyl-11,15-dihydroxypentanor-5,13-prostadienoic acid [MeSH Supplementary Concept]
- 9-fluoro-15-cyclohexyl-11,15-dihydroxypentanor-5,13-prostadienoic acid [MeSH Supplementary Concept]
- AL-12182 [MeSH Supplementary Concept]
- EMD 33290 [MeSH Supplementary Concept]
- EP 045 [MeSH Supplementary Concept]
- EP 092 [MeSH Supplementary Concept]
- GIF 0010 [MeSH Supplementary Concept]
- GIF 0037 [MeSH Supplementary Concept]
- U 62840 [MeSH Supplementary Concept]
See also (suggested by CISMeF)
- prostaglandins [MeSH Descriptor]
See also inter- (CISMeF)
- Product containing prostaglandin analog (product) [SNOMED CT concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Product containing prostaglandin analog (product) [SNOMED CT concept]
- Prostaglandin Analogue [NCIt concept]
- Prostaglandin analog (substance) [SNOMED CT concept]
Validated automatic mappings to BTNT
- prostaglandin analogues [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients